Eniola should approach this URL as a DISCOVERY TOOL to find better-matched opportunities rather than as a single programme to apply to. Among the eight listings, the only one where a creative case could be constructed is the CurePSP New Investigator Award — her Bayesian MCMC validation pipeline, ODE/RK45 pharmacological modelling, and CCT clinical trial architecture could be reframed toward tau propagation modelling or synaptic threshold dynamics in PSP/CBD if she could demonstrate genuine mechanistic overlap; however, this would require an authentic scientific pivot, not cosmetic reframing. More strategically, she should use scientifyRESEARCH's premium filters (career stage: early-career/pre-PhD, eligibility: LMIC, discipline: addiction neuroscience/computational pharmacology) to surface the minority of listings that are actually open to independent international researchers — the eight programmes shown on this page are collectively a poor eligibility fit.